Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

NicheProt: Cell-type-resolved proteomics of tissue compartments.

Created on 16 Jul 2026

Authors

Yi-Chien Wu, Dylan Schwartz, Elie Abi Khalil, Aditi Upadhye, Jalees Rehman, Steve Seung-Young Lee

Published in

Science advances. Volume 12. Issue 29. Pages eaee6237. Jul 17, 2026. Epub Jul 15, 2026.

Abstract

Spatial proteomics uncovers the molecular basis of cellular function in intact tissues. Laser capture microdissection coupled with mass spectrometry enables comprehensive proteomic profiling of selected tissue regions but typically does not support cell-type-specific proteomic analysis. We present NicheProt, a 3D optical microscopy-guided and photobleaching-mediated cell barcoding approach for isolating intact, specific cell types from defined microanatomical tissue compartments or niches. Using sequential bottom-up proteomic analysis, we defined two distinct phenotypes of CD11c+ dendritic cells based on their spatial locations in the inflamed mouse spleen. These two compartment-specific dendritic cell populations were characterized by proteomic signatures differing in the levels of 54 proteins. This 3D tissue microscopy-guided method offers cell-type and microregion-resolved proteomic analysis, facilitating the proteomic discovery of previously unrecognized cell subtypes and their functional roles in distinct tissue compartments.

PMID:
42455889
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement